Description
Release form
Coated tablets.
Packing
90 pcs.
Pharmacological action
Lorista N has a hypotensive effect.
Contraindications
Hypersensitivity to losartan, to sulfonamide derivatives and other components of the drug, anuria, severe impaired renal function (Cl creatinine Precautions: impaired water-electrolyte blood balance (hyponatremia, hypochloremic hypalonemia, dicloremia), renal artery stenosis or artery stenosis of a single kidney, diabetes mellitus, hypercalcemia, hyperuricemia and / or gout, aggravated allergic history (development of angioedema earlier with other drugs, including ACE inhibitors) and bronchial asthma, systemic blood diseases (including systemic lupus erythematosus), simultaneous appointment of NSAIDs, including COX-2 inhibitors.
Special instructions
May be prescribed with other antihypertensives. There is no need for special selection of the initial dose for elderly patients. The drug can increase the concentration of urea and creatinine in blood plasma in patients with bilateral renal artery stenosis or renal artery stenosis of a single kidney. Hydrochlorothiazide can enhance arterial hypotension and disturbances in the water-electrolyte balance (decrease in circulating blood volume, hyponatremia, hypochloremic alkalosis, hypomagnesemia, hypokalemia), impair glucose tolerance, reduce urinary calcium excretion and cause a transient, slight increase in plasma calcium concentration the concentration of cholesterol and triglycerides, provoke the occurrence of hyperuricemia and / or gout. Taking medications directly acting on the renin-angiotensin system during the second and third trimesters of pregnancy can lead to fetal death. If pregnancy occurs, drug withdrawal is indicated. The use of diuretics is usually not recommended for pregnant women due to the risk of jaundice in the fetus and newborn, and maternal thrombocytopenia. Diuretic therapy does not prevent the development of toxicosis of pregnancy.
Composition
1 tablet contains losartan potassium 50 mg, hydrochlorothiazide 12.5 mg.
Dosage and Administration
Inside, regardless of food intake.
Lorista N can be combined with other antihypertensive agents.
Arterial hypertension. The initial and maintenance dose is 1 tablet. Lorista N (50 / 12.5 mg) 1 time per day. The maximum antihypertensive effect is achieved within 3 weeks of therapy. To achieve a more pronounced effect, it is possible to increase the dose of the drug to 2 tablets. Lorista N (50 / 12.5 mg) 1 time per day. The maximum daily dose is 2 tablets. drug Lorista N.
In patients with reduced BCC (for example, while taking large doses of diuretics), the recommended initial dose of losartan in patients with hypovolemia is 25 mg once a day. In this regard, the therapy of Lorista N must be started after the abolition of diuretics and correction of hypovolemia.
In elderly patients and patients with moderate renal failure, including those on dialysis, no initial dose adjustment is required.
Reducing the risk of cardiovascular morbidity and mortality in patients with hypertension and left ventricular hypertrophy. The standard initial dose of losartan is 50 mg once a day.
Side effects of
From the blood and lymphatic system: infrequently – anemia, Shenlein-Genoch disease.
On the part of the immune system: rarely – anaphylactic reactions, angioedema (including swelling of the larynx and tongue, causing airway obstruction and / or swelling of the face, lips, pharynx).
From the side of the central nervous system and peripheral nervous system: often – headache, systemic and non-systemic dizziness, insomnia, fatigue infrequently – migraine.
From the cardiovascular system: often – orthostatic hypotension (dose-dependent), palpitations, tachycardia rarely – vasculitis.
From the respiratory system: often – cough, upper respiratory tract infections, pharyngitis, swelling of the nasal mucosa.
From the gastrointestinal tract: often – diarrhea, dyspepsia, nausea, vomiting, abdominal pain.
From the hepatobiliary system: rarely – hepatitis, impaired liver function.
From the skin and subcutaneous fat: infrequently – urticaria, pruritus.
From the side of the musculoskeletal system and connective tissue: often – myalgia, back pain infrequently – arthralgia.
Other: often – asthenia, weakness, peripheral edema, chest pain.
Laboratory indicators: often – hyperkalemia, an increase in the concentration of hemoglobin and hematocrit (not clinically significant) sometimes – a moderate increase in the level of urea and creatinine in the blood serum is very rare – an increase in the activity of liver and bilirubin enzymes.
Overdose
Losartan
Symptoms: marked decrease in blood pressure, tachycardia bradycardia due to parasympathetic (vagal) stimulation.
Treatment: forced diuresis, symptomatic therapy, hemodialysis is ineffective.
Hydrochlorothiazide
Symptoms: The most common symptoms are due to electrolyte deficiency (hypokalemia, hypochloremia, hyponatremia) and dehydration due to excessive diuresis. With the simultaneous administration of cardiac glycosides, hypokalemia can aggravate the course of arrhythmias.
Treatment: symptomatic.
Storage Conditions
In a dark place at a temperature not exceeding 25 ° C.
The Expiration of
is 3 years.
active substance
hydrochlorothiazide, losartan
Prescription terms from
pharmacies Prescription
lekarstvennaja form
tablets
KRKA d.d. Novo mesto AO, Slovenia
